Up for debate
Popular symposium addresses hot-button topics and urges members to get involved and work together.
S017 – The 2025 Debates: Controversies in Dermatology
1-4 p.m. | Friday, March 7
Valencia Ballroom B
New. Change. Unknown. Gray area. Such stages can be intimidating, even controversial.
Returning to this year’s Annual Meeting, S017 – The 2025 Debates: Controversies in Dermatology will present varying perspectives on thorny topics and sensitive subjects that impact many dermatology practices. Kenneth Y. Tsai, MD, PhD, FAAD, will moderate the panel presentations and live deliberations.
“An important goal of this session is to foster constructive discussion around these emerging areas of dermatologic importance,” said Dr. Tsai, who is vice chair of research in the department of pathology, and co-director of the Donald A. Adam Melanoma & Skin Cancer Center of Excellence, at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida.
This year, experts will examine three leading controversies:
- Applications of Artificial Intelligence in Dermatology — Yevgeniy Semenov, MD, MS, FAAD, and Shannon Wongvibulsin, MD, PhD
- The Clinical Utility of Molecular Testing in Melanoma and Keratinocyte Carcinomas — Emily Y. Chu, MD, PhD, FAAD, and David Cotter, MD, PhD, FAAD
- The Challenges of Melanoma (Over)Diagnosis and Screening — Adewole Shomari Adamson, MD, MPP, FAAD, and David Polsky, MD, PhD, FAAD
Kenneth Y. Tsai, MD, PhD, FAAD
In previous years, Dr. Tsai said speakers and members have continued to confer following the session’s conclusion. There is no limit of engagement on such significant issues.
“The most important thing I would like attendees to take away is to appreciate the deeply thoughtful insights our experts are bringing to the discussion, to actively participate, and to be better prepared to think about how to incorporate lessons learned in their own practices,” said Dr. Tsai.
